LEAP2 reduces postprandial glucose excursions and ad libitum food intake in healthy men

Cell Reports Medicine - Tập 3 Số 4 - Trang 100582 - 2022
Christoffer Hagemann1,2, Malene S. Jensen1, Stephanie Holm3, Lærke S. Gasbjerg1,3, Sarah Byberg3, Kirsa Skov‐Jeppesen3,4, Bolette Hartmann3,4, Jens J. Holst3,4, Flemming Dela3, Tina Vilsbøll1,5,6, Mikkel Christensen1,5,7, Birgitte Holst3, Filip K. Knop1,5,4,6
1Center for Clinical Metabolic Research, Copenhagen University Hospital – Herlev and Gentofte, Hellerup, Denmark
2Gubra, Hørsholm, Denmark
3Department of Biomedical Sciences, Faculty of Health and Medical, Sciences, University of Copenhagen, Copenhagen, Denmark
4Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
5Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
6Steno Diabetes Center Copenhagen, Gentofte, Denmark
7Department of Clinical Pharmacology, Copenhagen University Hospital Bispebjerg and Frederiksberg, Copenhagen, Denmark

Tóm tắt

Từ khóa


Tài liệu tham khảo

Müller, 2015, Ghrelin, Mol. Metab., 4, 437, 10.1016/j.molmet.2015.03.005

Kojima, 1999, Ghrelin is a growth-hormone-releasing acylated peptide from stomach, Nature, 402, 656, 10.1038/45230

Ariyasu, 2001, Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans, J. Clin. Endocrinol. Metab., 86, 4753, 10.1210/jcem.86.10.7885

Mani, 2019, LEAP2 changes with body mass and food intake in humans and mice, J. Clin. Invest., 129, 3909, 10.1172/JCI125332

Ge, 2018, LEAP2 is an endogenous antagonist of the ghrelin receptor, Cell Metab., 27, 461, 10.1016/j.cmet.2017.10.016

M’Kadmi, 2019, N-terminal liver-expressed antimicrobial peptide 2 (LEAP2) region exhibits inverse agonist activity toward the ghrelin receptor, J. Med. Chem., 62, 965, 10.1021/acs.jmedchem.8b01644

Hagemann, 2021, Identification and metabolic profiling of a novel human gut-derived LEAP2 fragment, J. Clin. Endocrinol. Metab., 106, e966, 10.1210/clinem/dgaa803

Baldini, 2019, The melanocortin pathway and control of appetite-progress and therapeutic implications, J. Endocrinol., 241, R1, 10.1530/JOE-18-0596

Maciejewski, 2016, Bariatric surgery and long-term durability of weight loss, JAMA Surg., 151, 1046, 10.1001/jamasurg.2016.2317

Moffett, 2021, The altered enteroendocrine reportoire following roux-en-Y-gastric bypass as an effector of weight loss and improved glycaemic control, Appetite, 156, 104807, 10.1016/j.appet.2020.104807

Svane, 2016, Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery, Int. J. Obes., 40, 1699, 10.1038/ijo.2016.121

Cornejo, 2021, The ups and downs of growth hormone secretagogue receptor signaling, FEBS J., 288, 7213, 10.1111/febs.15718

Druce, 2005, Ghrelin increases food intake in obese as well as lean subjects, Int. J. Obes., 29, 1130, 10.1038/sj.ijo.0803001

Islam, 2020, Liver-expressed antimicrobial peptide 2 antagonizes the effect of ghrelin in rodents, J. Endocrinol., 244, 13, 10.1530/JOE-19-0102

Shankar, 2021, LEAP2 deletion in mice enhances ghrelin’s actions as an orexigen and growth hormone secretagogue, Mol. Metab., 53, 101327, 10.1016/j.molmet.2021.101327

Barrile, 2019, Development of a novel fluorescent ligand of growth hormone secretagogue receptor based on the N-Terminal Leap2 region, Mol. Cell. Endocrinol., 498, 110573, 10.1016/j.mce.2019.110573

Gupta, 2021, High coexpression of the ghrelin and LEAP2 receptor GHSR with pancreatic polypeptide in mouse and human islets, Endocrinology, 162, bqab148, 10.1210/endocr/bqab148

Cornejo, 2019, Growth hormone secretagogue receptor signalling affects high-fat intake independently of plasma levels of ghrelin and LEAP2, in a 4-day binge eating model, J. Neuroendocrinol., 31, e12785, 10.1111/jne.12785

Levin, 2006, Ghrelin stimulates gastric emptying and hunger in normal-weight humans, J. Clin. Endocrinol. Metab., 91, 3296, 10.1210/jc.2005-2638

Willems, 2001, How useful is paracetamol absorption as a marker of gastric emptying? A systematic literature study, Dig. Dis. Sci., 46, 2256, 10.1023/A:1011935603893

Takaya, 2000, Ghrelin strongly stimulates growth hormone (GH) release in humans, J. Clin. Endocrinol. Metab., 85, 4908, 10.1210/jcem.85.12.7167

Traynard, 2020, Efficient pharmacokinetic modeling workflow with the MonolixSuite: a case study of remifentanil, CPT Pharmacometrics Syst. Pharmacol., 9, 198, 10.1002/psp4.12500

Flint, 1998, Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans, J. Clin. Invest., 101, 515, 10.1172/JCI990

Fujikawa, 2021, Central regulation of glucose metabolism in an insulin-dependent and -independent manner, J. Neuroendocrinol., 33, e12941, 10.1111/jne.12941

Møller, 2009, Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects, Endocr. Rev., 30, 152, 10.1210/er.2008-0027

DiGruccio, 2016, Comprehensive alpha, beta and delta cell transcriptomes reveal that ghrelin selectively activates delta cells and promotes somatostatin release from pancreatic islets, Mol. Metab., 5, 449, 10.1016/j.molmet.2016.04.007

Adriaenssens, 2016, Transcriptomic profiling of pancreatic alpha, beta and delta cell populations identifies delta cells as a principal target for ghrelin in mouse islets, Diabetologia, 59, 2156, 10.1007/s00125-016-4033-1

Lawlor, 2017, Single-cell transcriptomes identify human islet cell signatures and reveal cell-type-specific expression changes in type 2 diabetes, Genome Res., 27, 208, 10.1101/gr.212720.116

Svendsen, 2021, Paracrine regulation of somatostatin secretion by insulin and glucagon in mouse pancreatic islets, Diabetologia, 64, 142, 10.1007/s00125-020-05288-0

Lauritzen, 2020, Increased lipolysis after infusion of acylated ghrelin: a randomized, double-blinded placebo-controlled trial in hypopituitary patients, Clin. Endocrinol. (Oxf)., 93, 672, 10.1111/cen.14290

Nass, 2008, Evidence for acyl-ghrelin modulation of growth hormone release in the fed state, J. Clin. Endocrinol. Metab., 93, 1988, 10.1210/jc.2007-2234

Hartman, 1993, Evaluation of pulsatile patterns of growth hormone release in humans: a brief review, Am. J. Hum. Biol., 5, 603, 10.1002/ajhb.1310050603

Zigman, 2005, Mice lacking ghrelin receptors resist the development of diet-induced obesity, J. Clin. Invest., 115, 3564, 10.1172/JCI26002

Flint, 2000, Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies, Int. J. Obes., 24, 38, 10.1038/sj.ijo.0801083

Reeves, 2004, Reducing the time period of steady state does not affect the accuracy of energy expenditure measurements by indirect calorimetry, J. Appl. Physiol., 97, 130, 10.1152/japplphysiol.01212.2003

Sanchez-Delgado, 2018, Reliability of resting metabolic rate measurements in young adults: impact of methods for data analysis, Clin. Nutr., 37, 1618, 10.1016/j.clnu.2017.07.026

Fuller-Jackson, 2020, Effect of sex and sex steroids on brown adipose tissue heat production in humans, Eur. J. Endocrinol., 183, 343, 10.1530/EJE-20-0184

El Hadi, 2016, Infrared thermography for indirect assessment of activation of brown adipose tissue in lean and obese male subjects, Physiol. Meas., 37, N118, 10.1088/0967-3334/37/12/N118

Thuzar, 2018, Glucocorticoids suppress brown adipose tissue function in humans: a double-blind placebo-controlled study, Diabetes Obes. Metab., 20, 840, 10.1111/dom.13157

Orskov, 1991, Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine, J. Clin. Invest., 87, 415, 10.1172/JCI115012

Gregersen, 2008, Reproducibility and power of ad libitum energy intake assessed by repeated single meals, Am. J. Clin. Nutr., 87, 1277, 10.1093/ajcn/87.5.1277